Altered Associations between Pain Symptoms and Brain Morphometry in the Pain Matrix of HIV-Seropositive Individuals
Authors:
- 2 September 2017
- journal article
- research article
- Published by Springer Nature in Journal of Neuroimmune Pharmacology
- Vol. 13 (1) , 77-89
Abstract
Pain remains highly prevalent in HIV-seropositive (HIV+) patients despite their well-suppressed viremia with combined antiretroviral therapy. Investigating brain abnormalities within the pain matrix, and in relation to pain symptoms, in HIV+ participants may provide objective biomarkers and insights regarding their pain symptoms. We used Patient-Reported Outcome Measurement Information System (PROMIS®) pain questionnaire to evaluate pain symptoms (pain intensity, pain interference and pain behavior), and structural MRI to assess brain morphometry using FreeSurfer (cortical area, cortical thickness and subcortical volumes were evaluated in 12 regions within the pain matrix). Compared to seronegative (SN) controls, HIV+ participants had smaller surface areas in prefrontal pars triangularis (right: p = 0.04, left: p = 0.007) and right anterior cingulate cortex (p = 0.03) and smaller subcortical regions (thalamus: p ≤ 0.003 bilaterally; right putamen: p = 0.01), as well as higher pain scores (pain intensity-p = 0.005; pain interference-p = 0.008; pain-behavior-p = 0.04). Furthermore, higher pain scores were associated with larger cortical areas, thinner cortices and larger subcortical volumes in HIV+ participants; but smaller cortical areas, thicker cortices and smaller subcortical volumes in SN controls (interaction-p = 0.009 to p = 0.04). These group differences in the pain-associated brain abnormalities suggest that HIV+ individuals have abnormal pain responses. Since these abnormal pain-associated brain regions belong to the affective component of the pain matrix, affective symptoms may influence pain perception in HIV+ patients and should be treated along with their physical pain symptoms. Lastly, associations of lower pain scores with better physical or mental health scores, regardless of HIV-serostatus (p < 0.001), suggest adequate pain treatment would lead to better quality of life in all participants.Keywords
Funding Information
- National Institute on Drug Abuse (R01-DA-035659)
- National Institute on Drug Abuse (K24-DA16170)
- National Institute on Minority Health and Health Disparities (G12MD-007601)
This publication has 92 references indexed in Scilit:
- Fibromyalgia interacts with age to change the brainNeuroImage: Clinical, 2013
- Impact of apolipoprotein E ε4 and HIV on cognition and brain atrophy: Antagonistic pleiotropy and premature brain agingNeuroImage, 2011
- Lesion of the rostral anterior cingulate cortex eliminates the aversiveness of spontaneous neuropathic pain following partial or complete axotomyPain, 2011
- Disability, atrophy and cortical reorganization following spinal cord injuryBrain, 2011
- Gray Matter Volumes of Pain-Related Brain Areas Are Decreased in Fibromyalgia SyndromeThe Journal of Pain, 2011
- Subcortical brain atrophy persists even in HAART-regulated HIV diseaseBrain Imaging and Behavior, 2011
- The Patient-Reported Outcomes Measurement Information System (PROMIS) developed and tested its first wave of adult self-reported health outcome item banks: 2005–2008Journal of Clinical Epidemiology, 2010
- Development of a PROMIS item bank to measure pain interferencePain, 2010
- Shared mechanisms between chronic pain and neurodegenerative diseaseDrug Discovery Today: Disease Mechanisms, 2006
- Cortical Surface-Based AnalysisNeuroImage, 1999